Please login to the form below

Not currently logged in
Email:
Password:

Philip Payne completes Concept Life Sciences’ leadership team

He joins as chief commercial officer

Philip PayneIntegrated drug discovery and analytical company, Concept Life Sciences has appointed Philip Payne as its chief commercial officer, completing the group’s leadership line up.

Payne will work with Concept’s executive team and board to drive the group’s commercial strategy, leading the business development function and helping to guide the next stage of the company’s growth.

He will manage the sales team, including identification of new service areas, geographies and markets, supporting the broadening of Concept’s reach into Europe and the US.

He said: “I am excited to join Concept at this pivotal stage in the growth of the company, and look forward to working with the team to meet the group’s commercial and strategic objectives.”

Following 27 years’ experience Payne’s expertise lies in managing business integration development and pharma and biotech analytical and development services.

He joins from Aptuit, where he held various roles including vice president of sales and was responsible for the global business development team and strategic accounts.

Prior to this, he was business development director Europe and Asia for Sterile Technologies at Catalent Pharma Solutions.

Michael Fort, executive chairman, Concept Life Sciences, said: “Philip’s experience in managing multidisciplinary, international teams across a range of industries will be a great asset as Concept’s rapid rate of expansion continues.

“We are delighted to welcome Philip to the group.”

31st October 2017

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....